Drug Profile
Research programme: temozolomide analogues - Merck & Co./Pharminox
Alternative Names: DC-010-116Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Merck & Co; Pharminox
- Class Imidazoles; Small molecules; Triazines
- Mechanism of Action Alkylating agents
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Glioblastoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Glioblastoma in United Kingdom (PO)